Role of ribosomal protein S19-like plasma protein in blood coagulum resorption

Experimental and Molecular Pathology

Volumn 90, Issue 1, 2011, Pages 19-28

  Ota, Yoshihiko ^a   Chen, Jun ^a   Shin, Masashi ^b   Nishiura, Hiroshi ^a   Tokita, Kazutaka ^a   Shinohara, Masanori ^a   Yamamoto, Tetsuro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SOJO UNIVERSITY   (Japan)

Author keywords

C5a receptor; Chemotactic factor; Coagulum resorption; Monocytes macrophages; Ribosomal protein S19

Indexed keywords

PROTEIN ANTIBODY; RIBOSOME PROTEIN; RIBOSOME PROTEIN S19; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD CLOT; BLOOD CLOTTING; CELL SURFACE; COMPETITIVE INHIBITION; CONTROLLED STUDY; GUINEA PIG; IN VITRO STUDY; MACROPHAGE; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN FUNCTION; STRUCTURE ANALYSIS; THROMBUS;

ANIMALS; BLOOD COAGULATION; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; DIMERIZATION; GUINEA PIGS; HUMANS; MACROPHAGES; RIBOSOMAL PROTEINS; THROMBOSIS; TIME FACTORS;

CAVIA;

EID: 78650066557     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.11.008     Document Type: Article

References (34)

1. Cornwell D.G., Kruger F.A. Molecular complexes in the isolation and characterization of plasma lipoproteins. J. Lipid Res. 1961, 2:110-134.
2. Davies M.J., et al. The ultrastructure of organising experimental mural thrombi in the pig aorta. J. Pathol. 1975, 117:75-81.
3. Draptchinskaia N., et al. The gene encoding ribosomal proteinS19 is mutated in Diamond-Blackfan anemia. Nat. Genet. 1999, 21:169-174.
4. Feigl W., et al. Organisation of experimental thrombosis by blood cells. Evidence of the transformation of mononuclear cells into myofibroblasts and endothelial cells. Virchows Arch. A Pathol. Anat. Histopathol. 1985, 406:133-148.
5. Filip A.-M., et al. Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function. J. Biol. Chem. 2009, 284:7977-7985.
6. Horikawa T., et al. Detection of guinea pig macrophages by a new CD68 monoclonal antibody, PM-1K. J. Mol. Histol. 2006, 37:15-25.
7. Horino K., et al. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab. Invest. 1998, 78:603-617.
8. Horwitz D.A., Garrett M.A. Use of leukocyte chemotaxis in vitro to assay mediators generated by immune reactions. 1. Quantitation of mononuclear and polymorphonuclear leukocyte chemotaxis with polycarbonate (Nuclepore) filters. J. Immunol. 1971, 106:649-655.
9. Kukita I. Fifth component of complement (C5)-derived high molecular weight macrophage chemotactic factor in normal guinea pig serum. Inflammation 1987, 11:459-479.
10. Humphries J., et al. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J. Vasc. Surg. 1999, 30:894-899.
11. Matheson L.A., et al. Changes in macrophage function and morphology due to biomedical polyurethane surfaces undergoing biodegradation. J. Cell. Physiol. 2004, 199:8-19.
12. Matheson L.A., et al. Cyclic biaxial strain affects U937 macrophage-like morphology and enzymatic activities. J. Biomed. Mater. Res. A 2006, 76:52-62.
13. Matsson H., et al. Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation. Mol. Cell. Biol. 2004, 24:4032-4037.
14. Matsubara S., Y.T., Tsuruta T., Takagi K., Kambara T. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor: a molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am. J. Pathol. 1991, 138:1279-1291.
15. Matsumoto T., et al. Effect of uniaxial, cyclic stretch on the morphology of monocytes/macrophages in culture. J. Biomech. Eng. 1996, 118:420-422.
16. McGuinness C.L., et al. Recruitment of labelled monocytes by experimental venous thrombi. Thromb. Haemost. 2001, 85:1018-1024.
17. Miyazaki H., Hayashi K. Effects of cyclic strain on the morphology and phagocytosis of macrophages. Biomed. Mater. Eng. 2001, 11:301-309.
18. Nishimura T., et al. Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J. Biochem. 2001, 129:445-454.
19. Nishiura H., et al. Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein. J. Biol. Chem. 1996, 271:878-882.
20. Nishiura H., et al. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a. Lab. Invest. 1998, 78:1615-1623.
21. Nishiura H., et al. Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab. Invest. 1999, 79:915-923.
22. Nishiura H., et al. S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor. J. Cell. Biochem. 2005, 94:540-553.
23. Oda Y., et al. Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively. J. Biochem. 2008, 144:371-381.
24. Quarmby J., et al. A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis. J. Vasc. Surg. 1999, 30:139-147.
25. Revollo I., et al. Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes. Inflamm. Res. 2005, 54:82-90.
26. Semba U., et al. A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation. Am. J. Pathol. 2010, 176:1542-1551.
27. Shi L., et al. Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion. Virchows Arch. 2005, 447:747-755.
28. Shrestha A., et al. Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab. Invest. 1999, 79:1629-1642.
29. Shrestha A., et al. Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor. Am. J. Pathol. 2003, 162:1381-1388.
30. Singh I., et al. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation 2003, 107:869-875.
31. Tokita K., Yamamoto T. Differential role of neutrophils and monocytes during subcutaneous plasma extravasation. Lab. Invest. 2004, 84:1174-1184.
32. Umeda Y., et al. Guinea pig S19 ribosomal protein as precursor of C5a receptor-directed monocyte-selective leukocyte chemotactic factor. Inflamm. Res. 2004, 53:623-630.
33. Yamamoto T. Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer. Pathol. Int. 2000, 50:863-871.
34. Yamamoto T. Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes. Pathol. Int. 2007, 57:1-11.